Table 2.
Ingredients (mg/g) | 03Y | 07Y | 11Y | 15Y | 19Y |
---|---|---|---|---|---|
CG | 2.64 ± 0.05 a | 1.67 ± 0.04 ab | 1.65 ± 0.14 ab | 0.76 ± 0.04 b | 1.08 ± 0.08 ab |
ECG | 29.73 ± 0.96 b | 33.74 ± 0.37 ab | 33.94 ± 0.81 a | 30.34 ± 1.18 b | 26.51 ± 0.21 b |
GCG | 16.47 ± 0.39 a | 10.45 ± 0.48 b | 11.44 ± 0.21 b | 11.13 ± 0.51 b | 12.24 ± 0.24 b |
EGCG | 137.55 ± 1.04 a | 141.79 ± 0.04 a | 146.77 ± 0.85 a | 131.21 ± 0.98 a | 131.20 ± 0.63 a |
EC | 9.65 ± 0.11 b | 9.31 ±0.25 b | 12.41 ± 0.21 a | 13.52 ± 0.47 a | 14.37 ± 0.15 a |
C | 6.17 ± 0.03 a | 4.48 ± 0.13 ab | 6.49 ± 0.02 a | 5.46 ± 0.14 ab | 4.35 ± 0.26 b |
GC | 69.02 ± 0.00 b | 86.00 ± 1.28 a | 51.71 ± 0.85 c | 52.05 ± 1.87 c | 44.13 ± 0.73 c |
EGC | 38.65 ± 1.25 c | 33.02 ± 0.77 c | 45.03 ± 0.09 b | 58.59 ± 1.82 a | 63.67 ± 0.36 a |
GA | 10.88 ± 0.03 a | 9.79 ± 0.17 b | 6.40 ± 0.22 c | 5.54 ± 0.33 c | 3.45 ± 0.03 d |
CAFF | 92.67 ± 0.25 a | 90.45 ± 1.47 a | 75.85 ± 0.10 b | 88.99 ± 1.06 ab | 71.96 ± 0.01 b |
Ester catechins | 185.59 ± 4.96 a | 184.01 ± 2.66 a | 180.13 ± 7.42 a | 188.57 ± 7.20 a | 169.85 ± 2.02 a |
Non-ester catechins | 120.91 ± 2.13 a | 132.37 ± 0.72 a | 115.26 ± 0.15 a | 129.62 ± 4.30 a | 128.21 ± 2.61 a |
Total catechins | 306.50 ± 5.45 a | 328.23 ± 2.40 a | 308.18 ± 15.38 a | 303.29 ± 11.49 a | 298.06 ± 4.89 a |
a Values represent means ± SD (n = 4). One-way ANOVA analysis was performed between the treatments of multiple tea samples. The different lowercase letters (a, b, c) in the same group show the significant differences at p < 0.05 level. CG, catechin gallate; ECG, Epicatechin-3-gallate; GCG, gallocatechin-3-gallate; EGCG, epigallocatechin-3-gallate; EC, epicatechin; C, catechin; GC, gallocatechin; EGC, epigallocatechin; GA, gallic acid; CAFF, caffeine.